Visiongain Publishes Cold Laser Therapy Market Report 2021-2031

03 December 2020

Visiongain has published a new report on Cold Laser Therapy Market Report 2021-2031: Forecasts by Product (Instruments, and Accessories), by Application (Orthopedics, Dermatology, Dentistry, Neurology, Laser Acupuncture, Gynecology, and Others), by End-User (Hospitals, Homecare, Specialty Clinics, and Others), by Distribution Channel (Hospital Pharmacy, Retail pharmacy, Ecommerce and Others), PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Global Cold Laser Therapy market was valued at US$ xx Million in 2020 and is projected to reach at a market value of US$ xx Million by 2031. North America dominated the global Cold Laser Therapy market and is projected to witness CAGR of XX% during the first half of the forecast period i.e. 2021 to 2031.

COVID-19 Impact on Cold Laser Therapy Market
COVID-19 impact through different recovery models such as V-shaped, U-shaped, W-shaped, and L-shaped; has been taken into consideration while estimating and forecasting the Cold Laser Therapy market. Different recovery scenarios are also included in the report for all the segments and regions/nation. The recovery scenarios based on which market has been forecasted and analysed herein the report are mentioned below:

Market Drivers

Increasing Prevalence of Chronic and Non-Chronic Diseases
Prevalence of chronic and non-chronic diseases is increasing significantly due to rapidly changing lifestyle and increased consumption of malnutrition and smoking, tobacco, alcohol, less physical activity and others. Increasing prevalence of chronic and non-chronic diseases are creating a huge demand for the cold laser therapy as cold laser therapy is used for the treatment of various chronic and non-chronic diseases. Due to this reason increasing prevalence of chronic and non-chronic diseases around the world is working as a driver for the cold laser therapy market.

Increasing Geriatric Population around the World
Number of geriatric population is increasing very fast around the world. The region is facing rapid increase in the geriatric population. For instance: According to United Nations, Department of Economic and Social Affairs, Population Division geriatric population (persons aged 65 or over) was 702.9 million in 2019. Geriatric population are at high risk of developing muscle pain and wrinkle. Continuous increase in number of the geriatric population around the world is increasing the demand for cold laser therapy around the world as the cold laser therapy is used for skin rejuvenation, physical therapy practices as treatment for muscle pain. Due to which increasing geriatric population around the world is working as a driver for the cold laser therapy market.

Market Opportunities

Increasing Technological Advancements
Cold laser therapy is used for many applications such as acupuncture, wound healing, skin rejuvenation, aches and pains, inflammation, injuries and sprains and others. Researchers are conducting various research studies to develop new potential usage in traumatic brain injury (TBI), spinal cord injury, Alzheimer’s disease, Parkinson’s disease. Research and development activities for new potential usage are expected to help to increase demand of cold laser therapy. Currently, many of the manufacturers have launched their research studies for new cold laser therapy usage which is expected to create new opportunities for cold laser therapy market.

Competitive Landscape
Top companies (THOR Photomedicine Ltd, Erchonia Corporation, Theralase Technologies, Inc. and BioLight Technologies, LLC) constitute more than XX% share of the global Cold Laser Therapy market. Other companies profiled in the report include: Apira Science, Meditech International, Inc., DJO Global, Inc., BTL, Good Energies, Irradia among others Some of the key developments are listed below:

In 2019, Melbourne, FL has received U.S. Food and Drug Administration (FDA) approval for FX 635 low-level laser for the temporary relieving form chronic, nociceptive musculoskeletal pain. The approval will help company to increase its presence in the market.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Biopharmaceuticals Contract Manufacturing Market Report 2022-2032

Ageing population will be more susceptible to such diseases and is one of the key factors driving the growth of the global biological drugs market. In most of the developed world, the share of elderly population is almost touching a quarter of the population.

26 January 2022


Visiongain Publishes Topical Drug Delivery Market Report 2022-2032

Some of the factors driving the market growth are the increasing prevalence of skin and eye diseases, high incidences of burn incidences and the growing prevalence of diabetes.

26 January 2022


Visiongain Publishes Decentralized Clinical Trials Market Report 2022-2032

The growing adoption advanced e-clinical solutions, rising focus on clinical research, increasing investment in R&D, and adoption of decentralized clinical trials by biopharmaceutical companies are some of the major factors that drive the growth of the global decentralized clinical trials market.

24 January 2022


Visiongain Publishes Nasal Drug Delivery Technology Market Report 2022-2032

The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.

18 January 2022